[HTML][HTML] ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition
K Liu, X Chen, L Wu, S Chen, N Fang, L Cai… - BMC Pulmonary …, 2021 - Springer
Background ID1 is associated with resistance to the first generation of EGFR tyrosine kinase
inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC). However, the effect of ID1 …
inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC). However, the effect of ID1 …
埃克替尼与吉非替尼治疗EGFR 突变型晚期肺腺癌的临床疗效比较.
巫丽丽， 朱莹丽， 卓小露， 黄莉捺… - Chinese Journal of …, 2022 - search.ebscohost.com
Objective To compare the clinical efficacy, adverse events, and immunological function
status after medication of icotinib and gefitinib in the treatment of advanced lung …
status after medication of icotinib and gefitinib in the treatment of advanced lung …
[HTML][HTML] 非小细胞肺癌脑转移治疗的研究进展
韩雪， 李红梅 - Chinese Journal of Lung Cancer, 2020 - ncbi.nlm.nih.gov
肺癌是全世界癌症相关死亡的首要原因， 肺癌最常见的病理类型是非小细胞肺癌（ non-small
cell lung cancer, NSCLC）， NSCLC 引起的脑转移发病率一直呈上升趋势 …
cell lung cancer, NSCLC）， NSCLC 引起的脑转移发病率一直呈上升趋势 …
[HTML][HTML] 埃克替尼对一线化疗失败的晚期食管鳞状细胞癌患者的疗效及安全性研究
李豪， 包夏青， 刘显菊 - 实用临床医药杂志 - jcmp.yzu.edu.cn
埃克替尼对一线化疗失败的晚期食管鳞状细胞癌患者的疗效及安全性研究 高级检索 首页 期刊
动态 1.公告栏 2.期刊要闻 3.学术动态 编委专家 1.主编风采 审稿指南 1.专家审稿 2.审稿须知 3.自荐审稿 …
动态 1.公告栏 2.期刊要闻 3.学术动态 编委专家 1.主编风采 审稿指南 1.专家审稿 2.审稿须知 3.自荐审稿 …
Afatinib in the treatment of brain metastases of lung cancer with one rare EGFR mutation: a two-case report
L Sun, B Li, B Wang, J Li, J Li - Anti-Cancer Drugs, 2022 - journals.lww.com
Brain metastasis is one of the common distant metastases of lung cancer. The prognosis of
patients with brain metastasis is worse and the survival time is shorter. In this report, we …
patients with brain metastasis is worse and the survival time is shorter. In this report, we …
Overexpression of ID1 mediates resistance to osimertinib in T790M positive non-small cell lung cancer through epithelial-mesenchymal transition
K Liu, N Fang, L Wu, S Chen, L Cai, J Jia - 2020 - researchsquare.com
Objective To analyzed the effect of ID1 overexpression on osimertinib resistance to T790M
positive non-small cell lung cancer (NSCLC). Methods We established drug resistant cell …
positive non-small cell lung cancer (NSCLC). Methods We established drug resistant cell …
[引用][C] Synthesis of Quinazoline Derivatives as Intermediate Compounds for Tyrosine Kinase Inhibitors
P Santoso, RA Hafizah, A Danova, E Hermawati - Indonesian Journal of Natural …, 2024